Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Biotech
Aligos MASH prospect slashes liver fat in phase 2
Aligos is heralding a mid-stage MASH win after its candidate slashed liver fat at three different doses. Still, investors weren't impressed.
Gabrielle Masson
Sep 19, 2024 1:00pm
Basilea scores $268M BARDA funding for antifungals, antibiotics
Sep 19, 2024 7:45am
ESMO: Innovent links cytokine to colorectal cancer responses
Sep 18, 2024 9:53am
Novo inks $600M NanoVation deal to study genetic drugs ex-liver
Sep 18, 2024 9:03am
Capricor sells Europe rights to late-stage DMD therapy for $35M
Sep 18, 2024 5:55am
Despite ph. 3 miss, Alkeus sees path forward for eye disease med
Sep 17, 2024 10:58am